Temedica Raised an Additional EUR25M as part of Series B Capital

Temedica Raised an Additional EUR25M as part of Series B Capital

Temedica, an Munich, Germany-based health insight company, has raised EUR25M through Series B financing.

It brought the total amount raised to EUR42m and was led by MIG Capital and a family office in Munich.

The company is planning to utilize these funds to expand the reach of its platform, which gives a comprehensive view of the healthcare needs and experiences of millions of people through the integration of health-related data and its research and development efforts.

The company is led by its CEO and Founder, Gloria Seibert; Temedica is a company that provides health information, and’s goal is to facilitate individualized and customized healthcare with a focus on the patient’s requirements. Temedica achieves this by connecting health-related data from different sources. These are processed to provide insights to comply with the GDPR.

From over forty billion information points from more than 50,000 diagnoses, Temedica collects health-related data concerning issues like disease progression, treatment effectiveness, patient journeys, and medication adherence. The data collection platform combines information from various sources, including registry information, sales data for health-related products and services, insurance information, patient experience data, and – with explicit consent – the patients’ data generated by apps that aid patients.

Also, read Balance Receives a $350M Credit Facility from Viola Credit

The information gained from connected data provides tangible value to all parties involved within the healthcare system: patients, health professionals, clinics, research institutes as well as biotech and pharmaceutical businesses, as well as pharmacies.

Chris Evan was born in Dubai and raised in Montreal. He studied Computer Science and was so pleased with computer languages. He began writing after obsessing over technology.

Leave a Reply

Your email address will not be published. Required fields are marked *